Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer

•  Introduction •  Classification of miRNA‐related SNPs ‐  SNPs in miRNA processing machinery ‐  SNPs in pri‐, pre‐, mat‐miRNAs ‐  SNPs in miRNA‐binding sites •  MiRNA‐related SNPs and solid cancer ‐  Breast cancer ‐  Colorectal cancer ‐  Lung cancer ‐  Prostate cancer ‐  Renal cell carcinoma ‐  Cervical cancer ‐  Ovarian cancer ‐  Gastric cancer ‐  Bladder cancer ‐  Oesophageal cancer ‐  Hepatocellular carcinoma ‐  Head and neck cancer ‐  Thyroid cancer ‐  Glioma •  Conclusions and future directions

[1]  X. Gu,et al.  Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. , 2010, Human immunology.

[2]  Murat Gunel,et al.  Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome , 2005, Science.

[3]  J. Michálek,et al.  MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. , 2010, Neoplasma.

[4]  Hongbing Shen,et al.  Genetic variants of miRNA sequences and non-small cell lung cancer survival. , 2008, The Journal of clinical investigation.

[5]  Asaf Levy,et al.  Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high‐risk women , 2010, International journal of cancer.

[6]  F. Slack,et al.  microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. , 2009, Cancer research.

[7]  D. Bartel,et al.  MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.

[8]  K. Jażdżewski,et al.  Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer , 2009, Proceedings of the National Academy of Sciences.

[9]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[10]  P. Bugert,et al.  A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. , 2009, Carcinogenesis.

[11]  S. Hwang,et al.  Altered MicroRNA Expression in Cervical Carcinomas , 2008, Clinical Cancer Research.

[12]  S. Peng,et al.  Association of MicroRNA-196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population , 2010, Digestive Diseases and Sciences.

[13]  Dong Liang,et al.  Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. , 2010, Cancer research.

[14]  R. Vierkant,et al.  LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. , 2011, Cancer research.

[15]  J. Bertino,et al.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. , 2009, Pharmacogenomics.

[16]  S. Chanock,et al.  SNPs in cancer research and treatment , 2004, British Journal of Cancer.

[17]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[18]  Jian-Rong Yang,et al.  A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. , 2008, Carcinogenesis.

[19]  Rondi A. Butler,et al.  Mature MicroRNA Sequence Polymorphism in MIR196A2 Is Associated with Risk and Prognosis of Head and Neck Cancer , 2010, Clinical Cancer Research.

[20]  F. Slack,et al.  A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.

[21]  Marek Svoboda,et al.  Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy , 2010, Journal of experimental & clinical cancer research : CR.

[22]  M. Nikiforova,et al.  MicroRNA Expression Profiles in Thyroid Tumors , 2009, Endocrine pathology.

[23]  Li Yang,et al.  Hsa‐mir‐27a genetic variant contributes to gastric cancer susceptibility through affecting miR‐27a and target gene expression , 2010, Cancer science.

[24]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[25]  Zugen Chen,et al.  MicroRNA Profiling and Head and Neck Cancer , 2009, Comparative and functional genomics.

[26]  K. Hemminki,et al.  Polymorphisms within microRNA-binding sites and risk of sporadic colorectal cancer , 2008 .

[27]  G. Glinsky.  An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway , 2008, Cell cycle.

[28]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[29]  J. Yates,et al.  A role for the P-body component GW182 in microRNA function , 2005, Nature Cell Biology.

[30]  P. Bugert,et al.  A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk , 2010, Breast Cancer Research and Treatment.

[31]  C. Croce,et al.  MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.

[32]  Michel Georges,et al.  Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. , 2007, Current opinion in genetics & development.

[33]  C. Croce,et al.  Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. , 2010, Carcinogenesis.

[34]  Gang Xiong,et al.  A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han , 2010, Familial Cancer.

[35]  N. Yoo,et al.  Somatic mutations and losses of expression of microRNA regulation‐related genes AGO2 and TNRC6A in gastric and colorectal cancers , 2010, The Journal of pathology.

[36]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[37]  Hans Lehrach,et al.  MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy , 2009, Journal of cellular and molecular medicine.

[38]  K. Hemminki,et al.  Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. , 2007, Carcinogenesis.

[39]  Ligang Wu,et al.  PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits , 2006, Nucleic Acids Res..

[40]  Jana Novakova,et al.  MicroRNA involvement in glioblastoma pathogenesis. , 2009, Biochemical and biophysical research communications.

[41]  Wei Zhang,et al.  A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo , 2010, The Prostate.

[42]  Yuanqing Ye,et al.  Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. , 2008, Cancer research.

[43]  Jian Gu,et al.  Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma , 2008, Clinical Cancer Research.

[44]  Yang Liu,et al.  An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. , 2009, Carcinogenesis.

[45]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[46]  M. Kahn,et al.  A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  Hongbing Shen,et al.  Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. , 2010, Gynecologic oncology.

[48]  William Xu,et al.  MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility , 2010 .

[49]  David Smith,et al.  A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. , 2009, Cancer research.

[50]  Momiao Xiong,et al.  Investigation gene and microRNA expression in glioblastoma , 2009, 2009 International Joint Conference on Bioinformatics, Systems Biology and Intelligent Computing.

[51]  Andrew Feber,et al.  MicroRNA expression profiles of esophageal cancer. , 2008, The Journal of thoracic and cardiovascular surgery.

[52]  Marek Svoboda,et al.  MicroRNAs in colorectal cancer: translation of molecular biology into clinical application , 2009, Molecular Cancer.

[53]  Robert Johansson,et al.  Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. , 2008, Carcinogenesis.

[54]  George A Calin,et al.  An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset , 2009, Clinical Cancer Research.

[55]  Saiful Miah,et al.  Distinct microRNA alterations characterize high- and low-grade bladder cancer. , 2009, Cancer research.

[56]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Wen-Hsiung Li,et al.  Human polymorphism at microRNAs and microRNA target sites , 2007, Proceedings of the National Academy of Sciences.

[58]  Jin Young Park,et al.  Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer , 2009, Journal of Cancer Research and Clinical Oncology.

[59]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[60]  P. Bugert,et al.  Evaluation of SNPs in miR‐146a, miR196a2 and miR‐499 as low‐penetrance alleles in German and Italian familial breast cancer cases , 2010, Human mutation.

[61]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[62]  Hongbing Shen,et al.  A Functional Genetic Variant in microRNA-196a2 Is Associated with Increased Susceptibility of Lung Cancer in Chinese , 2009, Cancer Epidemiology Biomarkers & Prevention.

[63]  Xiaohua Li,et al.  Survival prediction of gastric cancer by a seven-microRNA signature , 2009, Gut.

[64]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[65]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.

[67]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[68]  Jian Gu,et al.  Genetic Variations in MicroRNA-Related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk , 2008, Cancer Prevention Research.

[69]  Robert A. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688)) , 2008 .

[70]  Wei Zhang,et al.  A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression , 2010, The Prostate.

[71]  Hongbing Shen,et al.  Common genetic variants in pre‐microRNAs were associated with increased risk of breast cancer in Chinese women , 2009, Human mutation.

[72]  B. Christensen,et al.  KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer. , 2010, Lung cancer.

[73]  C. Croce,et al.  MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[75]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[76]  H. McLeod,et al.  Cancer Pharmacogenomics: SNPs, Chips, and the Individual Patient , 2003, Cancer investigation.

[77]  Hua Zhao,et al.  A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. , 2008, Carcinogenesis.

[78]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[79]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[80]  Xifeng Wu,et al.  Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. , 2010, Carcinogenesis.

[81]  Feng-ping Huang,et al.  A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population , 2010, Journal of Cancer Research and Clinical Oncology.